Lemaitre Vascular Inc (LMAT) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Lemaitre Vascular Inc   (NASDAQ: LMAT)
 

Lemaitre Vascular Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lemaitre Vascular Inc 's inventory turnover ratio, the ratio that measures Lemaitre Vascular Inc 's ability to manage its supply chain, sequentially decreased to 2.56 in the third quarter 2026, but it does not raise any concerns as Lemaitre Vascular Inc continue to execute well, and the inventory turnover ratio remains above the average. Lemaitre Vascular Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 143 days, from 76 days, in the Jun 30 2026 quarter.

Within Healthcare sector Lemaitre Vascular Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

LMAT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lemaitre Vascular Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LMAT Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 28.43 % 3.25 % 0 % 5.56 % -11.76 %
Inventory Turnover Ratio (TTM) 2.56 4.82 - - -
LMAT's Total Ranking # # # # #
Average inventory processing period 142 76 - - -
Seq. Inventory Growth -0.78 % - - - -
Seq. Cost of Sales Growth -1.8 % 8.99 % -5.26 % 26.67 % -21.05 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



LMAT Company Profile >> Back to LMAT Efficiency Comparisons >> Compare LMAT Inventory Turnover Ratio to its Competitors

Financial Statements
Lemaitre Vascular Inc 's Inventories $ 59 Millions Visit LMAT's Balance sheet
Lemaitre Vascular Inc 's Cost of Revenues TTM $ 76 Millions Visit LMAT's Income Statement
What are LMAT's Sales? Visit LMAT's Sales by Segment

Other Inventory Turnover Ratios
Lemaitre Vascular Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LMAT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LMAT's Competitors
Inventory Turnover Ratio for LMAT's Suppliers
Inventory Turnover Ratio for LMAT's Customers

You may also want to know
LMAT's Sales Growth Rates LMAT's Pe Price to earnings ratio LMAT's Receivables Turnover Ratio LMAT's Stock Quote
LMAT's Net Income Growth Rates LMAT's Ps Price to Sales ratio LMAT's Sales per Employee LMAT's Asset Turnover Ratio
LMAT's Net Margin LMAT's Pb Price to Book ratio LMAT's Financial Strength Ratios LMAT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Dentsply Sirona Inc   2.65 $ 1,769.000  Millions$ 668  Millions
Avita Medical Inc   2.58 $ 14.936  Millions$ 6  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Abeona Therapeutics Inc   2.46 $ 13.630  Millions$ 6  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Tela Bio Inc   2.35 $ 26.999  Millions$ 11  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions
Aquestive Therapeutics Inc   2.34 $ 16.928  Millions$ 7  Millions
Lifevantage Corp  2.33 $ 39.482  Millions$ 17  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions

Date modified: 2026-11-08T19:32:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.